Corporate Disclosure
U2Bio maximizes shareholder profits and corporate value based on a stable and long-term growth strategy.
HomeInvestment InformationCorporate Disclosure
- Corporate Disclosure
- Financial Information Corporate Disclosure Investment Inquiries Announcement to Shareholders
| Number | Title | A person obligated to submit | Date |
|---|---|---|---|
| 7 | 임원ㆍ주요주주특정증권등소유상황보고서 | 김희찬 | 2023-03-10 |
| 6 | 임원ㆍ주요주주특정증권등소유상황보고서 | 김지원 | 2023-03-10 |
| 5 | 임원ㆍ주요주주특정증권등소유상황보고서 | 김진태 | 2023-03-08 |
| 4 | 권리락(무상증자) | 코넥스시장 | 2023-02-22 |
| 3 | 주주명부폐쇄기간또는기준일설정 | 유투바이오 | 2023-02-09 |
| 2 | 주권매매거래정지(무상증자) | 코넥스시장 | 2023-02-09 |
| 1 | 주요사항보고서(무상증자결정) | 유투바이오 | 2023-02-09 |